Medical tech company CONMED (NYSE:CNMD) reported Q1 CY2026 results , but sales fell by 1.3% year on year to $317 million. The company expects the full year’s revenue to be around $1.36 billion, close ...

CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the third quarter 2026 after the market close on Wednesday, October 28, 2026. The Company’s management will ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Looking back on surgical equipment & consumables - diversified stocks’ Q2 earnings, we examine this quarter’s best and worst ...

CONMED stock (ISIN US2074101013) was trading at USD 47.35 on the NYSE on October 5, 2026, up USD 1.03 or 2.22 percent from ...

CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the second quarter 2026 after the market close on Wednesday, July 29, 2026. The Company’s management will host ...

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at ...

CONMED stock (ISIN US2074101013) was last at USD 46.32 on the NYSE on October 2, 2026, with a daily gain of 0.85 percent. The ...

Garner provided Q4 revenue guidance of between $363 million and $370 million, representing mid-single-digit constant currency growth with about 100 basis points of tailwind from currency. Full year ...

Detailed price information for C O N M E D Corp (CNMD-N) from The Globe and Mail including charting and trades.

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will participate in fireside chats at the following two investor conferences in November: Conference: Stifel ...

CONMED Corporation CNMD is well-poised for growth in the coming quarters, courtesy of its broad product spectrum. The optimism led by a solid third-quarter 2022 performance, along with potential in ...